Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL: 2070)
Saudi Arabia
· Delayed Price · Currency is SAR 34.20
0.00 (0.00%)
Sep 11, 2024, 3:18 PM AST
Saudi Pharmaceutical Industries and Medical Appliances Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,562 | 1,653 | 1,422 | 1,460 | 1,555 | 1,487 | Upgrade
|
| Revenue Growth (YoY) | -6.00% | 16.27% | -2.60% | -6.14% | 4.60% | -1.10% | Upgrade
|
| Cost of Revenue | 878.96 | 958.47 | 864.5 | 846.73 | 869.96 | 996.21 | Upgrade
|
| Gross Profit | 683.07 | 694.61 | 557.31 | 613.05 | 685.32 | 490.64 | Upgrade
|
| Selling, General & Admin | 574.77 | 602.02 | 620.63 | 551.26 | 530.74 | 557.37 | Upgrade
|
| Research & Development | 48.32 | 41.46 | 42.65 | 29.07 | 20.35 | 13.37 | Upgrade
|
| Other Operating Expenses | -58.93 | -59.55 | -7.93 | 13.74 | -10.98 | -13.32 | Upgrade
|
| Operating Expenses | 579.56 | 597.65 | 665.39 | 580.22 | 541.58 | 653.16 | Upgrade
|
| Operating Income | 103.52 | 96.96 | -108.08 | 32.83 | 143.75 | -162.52 | Upgrade
|
| Interest Expense | -59.28 | -59.23 | -34.33 | -31.4 | -33.61 | -53.64 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 7 | 21.01 | Upgrade
|
| Earnings From Equity Investments | 16.02 | 20 | 20.44 | 11.41 | 38.21 | -14.26 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.42 | -4.32 | -14.38 | 15.03 | -0.47 | 4.9 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.17 | -3.17 | - | -1.49 | 0.3 | -108.53 | Upgrade
|
| EBT Excluding Unusual Items | 47.66 | 50.23 | -136.35 | 26.38 | 155.18 | -313.04 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -137.7 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.02 | 0.04 | 3.63 | 7.81 | 3.52 | 0.73 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.38 | 6.38 | 0.14 | -0.45 | - | 2.04 | Upgrade
|
| Legal Settlements | -17.82 | -20.47 | - | - | - | - | Upgrade
|
| Pretax Income | 36.25 | 36.18 | -132.59 | 33.73 | 158.7 | -447.98 | Upgrade
|
| Income Tax Expense | 39.24 | 45.26 | 25.9 | 12.35 | 43.9 | 29.94 | Upgrade
|
| Earnings From Continuing Operations | -3 | -9.08 | -158.48 | 21.38 | 114.81 | -477.91 | Upgrade
|
| Earnings From Discontinued Operations | 13.48 | 6.49 | -12.75 | -3.28 | -5.26 | -6.12 | Upgrade
|
| Net Income to Company | 10.49 | -2.59 | -171.23 | 18.1 | 109.54 | -484.04 | Upgrade
|
| Minority Interest in Earnings | -14.59 | -11.12 | 6.1 | 8.35 | 15.25 | 44.3 | Upgrade
|
| Net Income | -4.1 | -13.71 | -165.14 | 26.45 | 124.79 | -439.74 | Upgrade
|
| Net Income to Common | -4.1 | -13.71 | -165.14 | 26.45 | 124.79 | -439.74 | Upgrade
|
| Net Income Growth | - | - | - | -78.80% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 120 | 120 | 120 | 120 | 120 | 120 | Upgrade
|
| Shares Outstanding (Diluted) | 120 | 120 | 120 | 120 | 120 | 120 | Upgrade
|
| Shares Change (YoY) | -0.14% | -0.03% | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.03 | -0.11 | -1.38 | 0.22 | 1.04 | -3.66 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.11 | -1.38 | 0.22 | 1.04 | -3.66 | Upgrade
|
| EPS Growth | - | - | - | -78.80% | - | - | Upgrade
|
| Free Cash Flow | -53.21 | -63.68 | -177.51 | 10.47 | -155.02 | 26.01 | Upgrade
|
| Free Cash Flow Per Share | -0.44 | -0.53 | -1.48 | 0.09 | -1.29 | 0.22 | Upgrade
|
| Dividend Per Share | - | - | - | 0.600 | 1.000 | - | Upgrade
|
| Dividend Growth | - | - | - | -40.00% | - | - | Upgrade
|
| Gross Margin | 43.73% | 42.02% | 39.20% | 42.00% | 44.06% | 33.00% | Upgrade
|
| Operating Margin | 6.63% | 5.87% | -7.60% | 2.25% | 9.24% | -10.93% | Upgrade
|
| Profit Margin | -0.26% | -0.83% | -11.61% | 1.81% | 8.02% | -29.58% | Upgrade
|
| Free Cash Flow Margin | -3.41% | -3.85% | -12.48% | 0.72% | -9.97% | 1.75% | Upgrade
|
| EBITDA | 167.4 | 161.53 | -28.21 | 112.57 | 222.17 | -66.81 | Upgrade
|
| EBITDA Margin | 10.72% | 9.77% | -1.98% | 7.71% | 14.28% | -4.49% | Upgrade
|
| D&A For EBITDA | 63.88 | 64.57 | 79.87 | 79.74 | 78.43 | 95.71 | Upgrade
|
| EBIT | 103.52 | 96.96 | -108.08 | 32.83 | 143.75 | -162.52 | Upgrade
|
| EBIT Margin | 6.63% | 5.87% | -7.60% | 2.25% | 9.24% | -10.93% | Upgrade
|
| Effective Tax Rate | 108.26% | 125.08% | - | 36.60% | 27.66% | - | Upgrade
|
| Advertising Expenses | - | 56.75 | 41.89 | 40.43 | 35.98 | 71.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.